Device manufacturer, as written on reports
Medtronic Puerto Rico Villalba: medical device reports filed with FDA
46,144 reports name it as the manufacturer of the device involved, 2014–2026.
- 46,144
- reports naming it as manufacturer
- 0.2% of all MAUDE reports
- 38,174
- reports, 12 months to August 2026
- 7,140 in the 12 months before
- 54.1%
- classified as malfunction
- 62.3% across all reports
- 0.9%
- classified as death, as reported
- 0.9% across all reports
46,144 medical device reports received by FDA give Medtronic Puerto Rico Villalba as the manufacturer of the device involved, 0.2% of the MAUDE database, from February 2014 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
38,174 reports arrived in the 12 months to August 2026, up 435% from 7,140 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (54.1%), injury (45%) and death (0.9%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| CapSureFix Novus Lead MRI SureScan | Permanent pacemaker electrode | 17,728 | 17,554 | 1% |
| Sprint Quattro Secure S MRI SureScan | Implantable cardioverter defibrillator (non-crt) | 6,581 | 6,436 | 1.4% |
| SelectSecure MRI SureScan | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 5,450 | 4,994 | 1.3% |
| CapSureFix Novus MRI SureScan | Permanent pacemaker electrode | 3,509 | 3,243 | 1.3% |
| Sprint Quattro Secure MRI SureScan | Implantable cardioverter defibrillator (non-crt) | 2,246 | 1,903 | 1.4% |
| Epsila EV MRI SureScan | Permanent defibrillator electrodes | 1,162 | 1,023 | 1% |
| CapSure Sense Lead MRI SureScan | Permanent pacemaker electrode | 1,119 | 1,337 | 1% |
| Attain Stability Quad MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 968 | 837 | 1.3% |
| Attain Performa MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 743 | 647 | 1.4% |
| CapSure Fix MRI | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 724 | 600 | 0.6% |
| CapSure Epicardial Lead | Permanent pacemaker electrode | 687 | 760 | 1.5% |
| Attain Performa S MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 532 | 440 | 1.6% |
| OmniaSecure MRI SureScan | Permanent defibrillator electrodes | 456 | 462 | 1.1% |
| CapSureFix Lead | Permanent pacemaker electrode | 415 | 358 | 0.8% |
| Sprint Fidelis | Implantable cardioverter defibrillator (non-crt) | 397 | 340 | 14.1% |
| CapSure SP Novus Lead | Permanent pacemaker electrode | 389 | 331 | 1.1% |
| CapSure Z Novus Lead | Permanent pacemaker electrode | 341 | 313 | 0.4% |
| Attain Performa Straight MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 336 | 271 | 1.7% |
| Sensight | Stimulator, electrical, implanted, for parkinsonian tremor | 229 | 250 | 1.6% |
| CapSure SP | Permanent pacemaker electrode | 218 | 226 | 3.9% |
| Screw-In Lead | Permanent pacemaker electrode | 188 | 163 | 0.6% |
| Attain Ability MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 177 | 162 | 0.3% |
| Arctic Front Advance Pro Cardiac Cryoablation Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 152 | 152 | 2.5% |
| Sprint | Implantable cardioverter defibrillator (non-crt) | 143 | 161 | 2.4% |
| Sprint Quattro Lead | Implantable cardioverter defibrillator (non-crt) | 135 | 104 | 1.3% |
| Attain Bipolar Over The Wire Lead | Implantable pulse generator, pacemaker (non-crt) | 117 | 97 | 1.9% |
| Activa | Stimulator, electrical, implanted, for parkinsonian tremor | 116 | 1,112 | 0.6% |
| Attain Ability Plus MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 110 | 88 | 1.4% |
| Arctic Front Advance Cardiac Cryoablation Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 46 | 46 | 2.6% |
| Attain Over The Wire Lead | Implantable pulse generator, pacemaker (non-crt) | 33 | 51 | 2.4% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| DTB | Permanent pacemaker electrode | 24,616 | 53.3% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 8,579 | 18.6% |
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 6,320 | 13.7% |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker electrode | 2,949 | 6.4% |
| NVY | Permanent defibrillator electrodes | 2,697 | 5.8% |
| MHY | Stimulator, electrical, implanted, for parkinsonian tremor | 318 | 0.7% |
| OAE | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 213 | 0.5% |
| LWP | Implantable pulse generator, pacemaker (non-crt) | 173 | 0.4% |
| LGW | Stimulator, spinal-cord, totally implanted for pain relief | 89 | 0.2% |
| DRB | Stylet, catheter | 31 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Medtronic Puerto Rico Villalba reports
How many FDA device reports name Medtronic Puerto Rico Villalba as manufacturer?
46,144 reports through August 2026, 38,174 of them in the latest 12 months.
Which of its brands appear most often?
CapSureFix Novus Lead MRI SureScan (17,728), Sprint Quattro Secure S MRI SureScan (6,581), SelectSecure MRI SureScan (5,450), CapSureFix Novus MRI SureScan (3,509) and Sprint Quattro Secure MRI SureScan (2,246).
Which device types does it report on?
permanent pacemaker electrode (53.3%), implantable cardioverter defibrillator (non-crt) (18.6%), drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (13.7%) and drug eluting permanent left ventricular (lv) pacemaker electrode (6.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.